Vintec
®
: When product market fit drives label extension and territories
diversification
Vintec
®
is the name of Bi-PA’s bio fungicide which was launched six years
ago against Esca in vineyards and vine nurseries by Belchim Crop Protection.
Vintec is based on the specific
Trichoderma
strain named SC1, isolated from
hazelnut plant tissue and registered for crop protection use. While diseases
in perennial crops generally infect the annually produced organs and
structures like flowers, fruits and leaves, Esca infects the trunk through the
pruning wounds and, after a few years, it can kill the entire plant, generating
significant economic losses.
Vintec expectations were high, customers and vine growers showed their
enthusiasm by filling meeting rooms, seminars and field tours but sales did
not take off as foreseen. To trigger the demand for Vintec, it was necessary to
build awareness of the magnitude of the issue caused by lack of protection
on the pruning wounds. In fact, Esca takes a few years to spread inside the
trunk, leading to a lack of rapid visual results which is contrary to the vine
growers’ expectations.
Instead of stopping the developments with biologicals, Vintec became
Belchim’s case study to understand how to position, promote and sell a
biological product in a specific market. Several collaborations were initiated
with leading academic scientists working on Esca to better understand
Vintec’s mode of action and its intrinsic value while contacting customers,
farmers and nurseries across Europe to understand their specific needs and
the drivers for their decisions.
The Vintec project finally pivoted in 2020 with the registration of its use
against Botrytis in indoor tomato in Spain. A thorough approach was
developed to ensure the right market fit, thanks to collective work on
Vintec’s value proposition. It resulted in a successful product launch, even in
the context of a new and unexpected challenge: Covid-19.
128




